Sign in

CIK 0001116463

  • Accelerated filer

ORASURE TECHNOLOGIES INC

Sign in to watch
Ticker
OSUR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364370966
Phone
+1 503-641-6115
Business address
220 E FIRST ST, BETHLEHEM, PA, 18015
  1. 4 Grant or award Director acquired 8,965 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award EVP & BU Lead - Molecular acquired 52,992 shares (grant or award)
  4. 4 Grant or award EVP & BU Lead - Infectious acquired 67,818 shares (grant or award)
  5. 4 Grant or award VP, Finance and Controller acquired 7,545 shares (grant or award)
  6. 4 Grant or award CFO acquired 47,908 shares (grant or award)
  7. 4 Grant or award SVP & General Counsel acquired 58,201 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 84,997 shares (grant or award)
  9. 4 Grant or award Director acquired 13,432 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Director acquired 15,330 shares (grant or award)
  12. 4 Grant or award Director acquired 12,382 shares (grant or award)
  13. 4 Grant or award Director acquired 12,382 shares (grant or award)
  14. 4 Grant or award Director acquired 12,382 shares (grant or award)
  15. 4 Grant or award Director acquired 12,382 shares (grant or award)
  16. 4 Grant or award Director acquired 12,382 shares (grant or award)
  17. 4 Open-market buy President and CEO bought 1,000 shares at $8.56 ($8,560)
  18. 4 Open-market buy SVP & General Counsel bought 10,000 shares at an average $8.55 ($85,487)
  19. 4 Open-market buy CFO bought 10,000 shares at an average $9.03 ($90,314)
  20. 4 Shares withheld for taxes CFO gave up 1,359 shares (to pay taxes)

Page 10 of 37 · 723 filings